OEM News
- All News
- Breaking News
- Certifications
- Clinical Trials
- Device Approvals & Patents
- Financial & Deals
- International
- Market Data & Trends
- ODT Best Bets
- OEM News
- Orthopedic Innovators
- People
- Product & Service Releases
- Products
- Quality, Recalls & Risk
- Regulatory & Legal
- Supplier & Contract Mfg.
- Videobites
-
Extremities
ADSM-Synchro Medical Acquired by Tyber Medical
The acquisition will play a key role in strengthening Tyber Medical's international presence and fueling its global growth strategy.Charles Sternberg, Associate Editor 02.01.23
-
Spine/Neurology
Mobi-C Cervical Disc Replacement Procedures Top 200,000
Milestone aligns with 10-year anniversary of Mobi-C's FDA approval for treatment of one and two levels of the cervical spine.Michael Barbella, Managing Editor 01.31.23
-
Roche, Sysnav Partner on Movement Tracking Tech for Neuromuscular Disorders
Sysnav and Roche expanded their partnership across multiple programs to build meaningful digital endpoints.Sam Brusco, Associate Editor 01.27.23
-
Spine/Neurology
Orthofix Launches the Mariner Deformity System
The System provides a comprehensive implant offering while reducing the number of surgical trays typically associated with deformity surgery.Michael Barbella, Managing Editor 01.26.23
-
Tyber Medical Hires 2 New Execs
James Abraham takes on new chief commercial officer role; Damien Sabilla appointed as CFO.Sam Brusco, Associate Editor 01.25.23
-
Large Joint
Miach Ortho Raises $40M in Series B Funding
Will fund ongoing operations and expanded U.S. rollout of the BEAR implant.Sam Brusco, Associate Editor 01.25.23
-
Hanger CEO Asar to Retire; COO Pete Stoy to Assume Role
Vinit Asar will retire from his CEO role on May 1 after over a decade leading the company.Sam Brusco, Associate Editor 01.24.23
-
Spine/Neurology
icotec Earns FDA Nod for Ø 4.5mm VADER Pedicle Screws
Made from the firm’s proprietary BlackArmor carbon/PEEK composite material.Sam Brusco, Associate Editor 01.24.23
-
Spine/Neurology
NeuroMetrix Releases DPNCheck 2.0 Point-of-Care Tool
Fast, accurate, quantitative screening test for peripheral neuropathy.Sam Brusco, Associate Editor 01.23.23
-
DePuy to Pay $9.75 Million to Resolve Allegations of Providing Illegal Kickbacks
The United States contends that DePuy knowingly and willfully provided free DePuy products, worth over $100,000, to a surgeon for his overseas surgeries.Charles Sternberg, Associate Editor 01.20.23
-
Trauma/Sports
Conventus Flower Orthopedics’ Flex-Thread Ulna Intramedullary Nail System Cleared by FDA
Expands the company's Flex-Thread technology platform.Charles Sternberg, Associate Editor 01.19.23
-
Large Joint
Hip Innovation Technology Initiates FDA Approved Investigational Device Exemption Study
Completes first U.S. implantation of its reverse hip replacement system for the treatment of total hip arthroplasty.Charles Sternberg, Associate Editor 01.18.23
-
Biologics | Large Joint
Orthogen's IDE Trial for Knee OA Gets FDA Nod
Orthogen to launch pivotal trial of novel therapy for knee osteoarthritis.Sam Brusco, Associate Editor 01.18.23
-
First Patient Enrolled in Stage 2 Study of Rheumatoid Arthritis
RESET-RA Study results will support SetPoint Medical's FDA submission for approval of promising treatment approach for RA.Michael Barbella, Managing Editor 01.18.23
-
Spine/Neurology
FDA OKs VySpine's LumiVy Lumbar IBF with NanoVy Ti
Indicated for intervertebral body fusion at one level or two contiguous levels in the lumbar spine, from L2 to S1.Sam Brusco, Associate Editor 01.17.23
-
Extremities
Enovis Expands DynaClip Family With Debut of New Staples
The procedure-specific staples combine strength with sustained dynamic compression for mid-foot and first MTP joint fusions.Michael Barbella, Managing Editor 01.17.23
-
Biologics | Large Joint
Lipogems Begins ARISE IDE Study for Knee OA
Will compare its MicroFat autologous, intra-articular injection versus corticosteroid injection to treat knee osteoarthritis (OA).Sam Brusco, Associate Editor 01.16.23
-
Spine/Neurology
Scoliosis Technologies Merges with European Technology to Form Scoli3D
New company’s mission is to deliver non-surgical scoliosis treatment with guaranteed results for children in the United States.Charles Sternberg, Associate Editor 01.16.23
-
Large Joint
Vericel Shares Accelerated Launch Timeline for MACI Arthroscopic Program
Anticipates an accelerated potential commercial launch of arthroscopic MACI in 2024.Charles Sternberg, Associate Editor 01.11.23
-
Avanos Medical Names 2 New Execs
Michael Greiner named chief transformation officer; Kerr Holbrook named senior VP and chief commercial officer.Sam Brusco, Associate Editor 01.11.23
